Due to the increasing evidence of the regulatory roles of BMP2 in angiogenesis and CM functionality, interest in utilizing BMP2 as a treatment for CAD and the underlying myocardial ischemia has emerged (20, 32, 33). This evidence concerns the gene BMP2 and coronary artery disorder.